1-ethyl-2-benzimidazolinone has been researched along with potassium chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, T; Ito, Y; Kondo, M; Kume, H; Nakayama, S; Sato, S; Shimokata, K; Son, M | 1 |
| Aso, T; Azuma, H; Iwasaki-Kurashige, K; Loyaga-Rendon, RY; Sakamoto, S; Takahashi, R | 1 |
2 other study(ies) available for 1-ethyl-2-benzimidazolinone and potassium chloride
| Article | Year |
|---|---|
ATP release triggered by activation of the Ca2+-activated K+ channel in human airway Calu-3 cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Benzimidazoles; Bumetanide; Calcium; Cell Size; Charybdotoxin; Chlorzoxazone; Colforsin; Cystic Fibrosis Transmembrane Conductance Regulator; Cytosol; Epithelial Cells; Glyburide; Humans; Ionomycin; Isoproterenol; Luciferases; Lung; Potassium Channels, Calcium-Activated; Potassium Chloride; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1 | 2004 |
Mediators involved in decreasing peripheral vascular resistance with carbachol in the rat hind limb perfusion model.
Topics: Animals; Benzimidazoles; Carbachol; Cyclic GMP; Endothelium, Vascular; Female; Gap Junctions; Hindlimb; Nitric Oxide; Nitroarginine; Nitroprusside; Perfusion; Potassium Chloride; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasodilation | 2005 |